Fn14 Participates in Neuropathic Pain Through NF-κB Pathway in Primary Sensory Neurons
- 293 Downloads
Fibroblast growth factor-inducible-14 (Fn14), a receptor for tumor necrosis-like weak inducer of apoptosis, is expressed in the neurons of dorsal root ganglion (DRG). Its mRNA is increased in the injured DRG following peripheral nerve injury. Whether this increase contributes to neuropathic pain is unknown. We reported here that peripheral nerve injury caused by spinal nerve ligation (SNL) increased the expression of Fn14 at both protein and mRNA levels in the injured DRG. Blocking this increase attenuated the development of SNL-induced mechanical, thermal, and cold pain hypersensitivities. Conversely, mimicking this increase produced the increases in the levels of phosphorylated extracellular signal-regulated kinase ½ and glial fibrillary acidic protein in ipsilateral dorsal horn and the enhanced responses to mechanical, thermal, and cold stimuli in the absence of SNL. Mechanistically, the increased Fn14 activated the NF-κB pathway through promoting the translocation of p65 into the nucleus of the injured DRG neurons. Our findings suggest that Fn14 may be a potential target for the therapeutic treatment of peripheral neuropathic pain.
KeywordsFn14 NF-κB pathway Primary sensory neurons Neuropathic pain
This work was supported by the grants (NS094664, NS094224, and DA033390) from the National Institutes of Health (Bethesda, Maryland, USA).
Compliance with Ethical Standards
The Institutional Animal Care and Use Committee at New Jersey Medical School, Rutgers approved all experimental procedures (IACUC approved number 13035A2E0716).
Conflict of Interests
The authors declare that they have no competing interests.
- 1.DiBonaventura MD, Sadosky A, Concialdi K, Hopps M, Kudel I, Parsons B, Cappelleri JC, Hlavacek P et al (2017) The prevalence of probable neuropathic pain in the US: results from a multimodal general-population health survey. J Pain Res 10:2525–2538. https://doi.org/10.2147/JPR.S127014 CrossRefGoogle Scholar
- 6.Yang DZ, Sin B, Beckhusen J, Xia D, Khaimova R, Iliev I (2018) Opioid-induced hyperalgesia in the nonsurgical setting: A systematic review. Am J Ther:1. https://doi.org/10.1097/MJT.0000000000000734
- 10.Polavarapu R, Gongora MC, Winkles JA, Yepes M (2005) Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation. J Neurosci 25(44):10094–10100. https://doi.org/10.1523/JNEUROSCI.3382-05.2005 CrossRefGoogle Scholar
- 11.Qi X, Qin L, Du R, Chen Y, Lei M, Deng M, Wang J (2017) Lipopolysaccharide upregulated intestinal epithelial cell expression of Fn14 and activation of Fn14 signaling amplify intestinal TLR4-mediated inflammation. Front Cell Infect Microbiol 7:315. https://doi.org/10.3389/fcimb.2017.00315 CrossRefGoogle Scholar
- 17.Wilhelm A, Shepherd EL, Amatucci A, Munir M, Reynolds G, Humphreys E, Resheq Y, Adams DH et al (2016) Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation. J Pathol 239(1):109–121. https://doi.org/10.1002/path.4707 CrossRefGoogle Scholar
- 18.Tanabe K, Bonilla I, Winkles JA, Strittmatter SM (2003) Fibroblast growth factor-inducible-14 is induced in axotomized neurons and promotes neurite outgrowth. J Neurosci 23(29):9675–9686. https://doi.org/10.1186/1471-2202-4-27
- 19.Yepes M (2007) TWEAK and the central nervous system. Mol Neurobiol 35(3):255–265. https://doi.org/10.1007/s12035-007-0024-z
- 20.Yepes M (2007) Tweak and FN14 in central nervous system health and disease. Front Biosci 12:2772–2781. https://doi.org/10.2741/2271
- 21.Desplat-Jego S, Creidy R, Varriale S, Allaire N, Luo Y, Bernard D, Hahm K, Burkly L et al (2005) Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis. Clin Immunol 117(1):15–23. https://doi.org/10.1016/j.clim.2005.06.005 CrossRefGoogle Scholar
- 22.Wen J, Chen CH, Stock A, Doerner J, Gulinello M, Putterman C (2016) Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in non-autoimmune mice. Brain Behav Immun 54:27–37. https://doi.org/10.1016/j.bbi.2015.12.017 CrossRefGoogle Scholar
- 23.Frauenknecht K, Bargiotas P, Bauer H, von Landenberg P, Schwaninger M, Sommer C (2010) Neuroprotective effect of Fn14 deficiency is associated with induction of the granulocyte-colony stimulating factor (G-CSF) pathway in experimental stroke and enhanced by a pathogenic human antiphospholipid antibody. J Neuroimmunol 227(1–2):1–9. https://doi.org/10.1016/j.jneuroim.2010.05.043 CrossRefGoogle Scholar
- 24.Pelekanou V, Notas G, Kampa M, Tsentelierou E, Stathopoulos EN, Tsapis A, Castanas E (2013) BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis. PLoS One 8(12):e83250. https://doi.org/10.1371/journal.pone.0083250 CrossRefGoogle Scholar
- 28.Liaw WJ, Zhu XG, Yaster M, Johns RA, Gauda EB, Tao YX (2008) Distinct expression of synaptic NR2A and NR2B in the central nervous system and impaired morphine tolerance and physical dependence in mice deficient in postsynaptic density-93 protein. Mol Pain 4:45. https://doi.org/10.1186/1744-8069-4-45 CrossRefGoogle Scholar
- 30.Tao YX, Rumbaugh G, Wang GD, Petralia RS, Zhao C, Kauer FW, Tao F, Zhuo M et al (2003) Impaired NMDA receptor-mediated postsynaptic function and blunted NMDA receptor-dependent persistent pain in mice lacking postsynaptic density-93 protein. J Neurosci 23(17):6703–6712. https://doi.org/10.1523/JNEUROSCI.23-17-06703.2003
- 35.Hosokawa Y, Hosokawa I, Shindo S, Ozaki K, Nakae H, Matsuo T (2012) Tumor necrosis factor-like weak inducer of apoptosis increases CC chemokine ligand 20 production in interleukin 1beta-stimulated human gingival fibroblasts. Hum Immunol 73(5):470–473. https://doi.org/10.1016/j.humimm.2012.02.021 CrossRefGoogle Scholar
- 36.Echeverry R, Wu F, Haile WB, Wu J, Yepes M (2012) The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system. J Neuroinflammation 9:45. https://doi.org/10.1186/1742-2094-9-45 CrossRefGoogle Scholar
- 38.Zhang YC, Huo FC, Wei LL, Gong CC, Pan YJ, Mou J, Pei DS (2017) PAK5-mediated phosphorylation and nuclear translocation of NF-kappaB-p65 promotes breast cancer cell proliferation in vitro and in vivo. J Exp Clin Cancer Res : CR 36(1):146. https://doi.org/10.1186/s13046-017-0610-5 CrossRefGoogle Scholar
- 39.Tomita H, Tabata K, Takahashi M, Nishiyama F, Sugano E (2016) Light induces translocation of NF-kappaB p65 to the mitochondria and suppresses expression of cytochrome c oxidase subunit III (COX III) in the rat retina. Biochem Biophys Res Commun 473(4):1013–1018. https://doi.org/10.1016/j.bbrc.2016.04.008 CrossRefGoogle Scholar
- 41.Xu T, Li D, Zhou X, Ouyang HD, Zhou LJ, Zhou H, Zhang HM, Wei XH et al (2017) Oral application of magnesium-L-Threonate attenuates vincristine-induced allodynia and hyperalgesia by normalization of tumor necrosis factor-alpha/nuclear factor-kappaB signaling. Anesthesiology 126(6):1151–1168. https://doi.org/10.1097/ALN.0000000000001601 CrossRefGoogle Scholar
- 43.Zhang HH, Hu J, Zhou YL, Hu S, Wang YM, Chen W, Xiao Y, Huang LY et al (2013) Promoted interaction of nuclear factor-kappaB with demethylated cystathionine-beta-synthetase gene contributes to gastric hypersensitivity in diabetic rats. J Neurosci 33(21):9028–9038. https://doi.org/10.1523/JNEUROSCI.1068-13.2013 CrossRefGoogle Scholar
- 44.Zhang HH, Hu J, Zhou YL, Qin X, Song ZY, Yang PP, Hu S, Jiang X et al (2015) Promoted interaction of nuclear factor-kappaB with demethylated purinergic P2X3 receptor gene contributes to neuropathic pain in rats with diabetes. Diabetes 64(12):4272–4284. https://doi.org/10.2337/db15-0138 CrossRefGoogle Scholar